These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37403405)

  • 21. Factors influencing uptake, continuation, and discontinuation of oral PrEP among clients at sex worker and MSM facilities in South Africa.
    Pillay D; Stankevitz K; Lanham M; Ridgeway K; Murire M; Briedenhann E; Jenkins S; Subedar H; Hoke T; Mullick S
    PLoS One; 2020; 15(4):e0228620. PubMed ID: 32352969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MPrEP+ study protocol: a prospective cohort study assessing the feasibility and acceptability of an HIV pre-exposure prophylaxis (PrEP) strategy for male clients of female sex workers in Kisumu, Kenya.
    Mantell J; Franks J; Zerbe A; Lamb MR; Reed DM; Omollo D; Lahuerta M; Naitore D; El-Sadr WM; Agot K
    BMJ Open; 2022 Nov; 12(11):e064037. PubMed ID: 36332953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. "Since both of us are using antiretrovirals, we have been supportive to each other": facilitators and barriers of pre-exposure prophylaxis use in heterosexual HIV serodiscordant couples in Kisumu, Kenya.
    Patel RC; Stanford-Moore G; Odoyo J; Pyra M; Wakhungu I; Anand K; Bukusi EA; Baeten JM; Brown JM
    J Int AIDS Soc; 2016; 19(1):21134. PubMed ID: 27964776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact along the HIV pre-exposure prophylaxis "cascade of prevention" in western Kenya: a mathematical modelling study.
    Bershteyn A; Sharma M; Akullian AN; Peebles K; Sarkar S; Braithwaite RS; Mudimu E
    J Int AIDS Soc; 2020 Jun; 23 Suppl 3(Suppl 3):e25527. PubMed ID: 32602669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adherence to recommendations for ART and targeted PrEP use among HIV serodiscordant couples in East Africa: the "PrEP as a bridge to ART" strategy.
    Musinguzi N; Kidoguchi L; Mugo NR; Ngure K; Katabira E; Celum CL; Baeten JM; Heffron R; Haberer JE;
    BMC Public Health; 2020 Oct; 20(1):1621. PubMed ID: 33115478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrating oral PrEP delivery among African women in a large HIV endpoint-driven clinical trial.
    Beesham I; Welch JD; Heffron R; Pleaner M; Kidoguchi L; Palanee-Phillips T; Ahmed K; Baron D; Bukusi EA; Louw C; Mastro TD; Smit J; Batting JR; Malahleha M; Bailey VC; Beksinska M; Donnell D; Baeten JM;
    J Int AIDS Soc; 2020 May; 23(5):e25491. PubMed ID: 32396700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PrEP distribution in pharmacies: a systematic review.
    Kennedy CE; Yeh PT; Atkins K; Ferguson L; Baggaley R; Narasimhan M
    BMJ Open; 2022 Feb; 12(2):e054121. PubMed ID: 35190430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PrEP use and HIV seroconversion rates in adolescent girls and young women from Kenya and South Africa: the POWER demonstration project.
    Celum CL; Bukusi EA; Bekker LG; Delany-Moretlwe S; Kidoguchi L; Omollo V; Rousseau E; Travill D; Morton JF; Mogaka F; O'Malley G; Barnabee G; van der Straten A; Donnell D; Parikh UM; Kudrick L; Anderson PL; Haberer JE; Wu L; Heffron R; Johnson R; Morrison S; Baeten JM;
    J Int AIDS Soc; 2022 Jul; 25(7):e25962. PubMed ID: 35822945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Daily Oral Pre-exposure Prophylaxis (PrEP) Continuation Among Women from Durban, South Africa, Who Initiated PrEP as Standard of Care for HIV Prevention in a Clinical Trial.
    Beesham I; Joseph Davey DL; Beksinska M; Bosman S; Smit J; Mansoor LE
    AIDS Behav; 2022 Aug; 26(8):2623-2631. PubMed ID: 35122575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV Pre-exposure Prophylaxis Uptake and Continuation Among Key Populations in Cameroon: Lessons Learned From the CHAMP Program.
    Ndenkeh JJN; Bowring AL; Njindam IM; Folem RD; Fako GCH; Ngueguim FG; Gayou OL; Lepawa K; Minka CM; Batoum CM; Georges S; Temgoua E; Nzima V; Kob DA; Akiy ZZ; Philbrick W; Levitt D; Curry D; Baral S
    J Acquir Immune Defic Syndr; 2022 Sep; 91(1):39-46. PubMed ID: 35536113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perinatal outcomes following maternal pre-exposure prophylaxis (PrEP) use during pregnancy: results from a large PrEP implementation program in Kenya.
    Dettinger JC; Kinuthia J; Pintye J; Abuna F; Begnel E; Mugwanya K; Sila J; Lagat H; Baeten JM; John-Stewart G
    J Int AIDS Soc; 2019 Sep; 22(9):e25378. PubMed ID: 31498563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing longitudinal patterns of depressive symptoms and the influence of symptom trajectories on HIV pre-exposure prophylaxis adherence among adolescent girls in the HPTN 082 randomized controlled trial.
    Velloza J; Hosek S; Donnell D; Anderson PL; Chirenje M; Mgodi N; Bekker LG; Delany-Moretlwe S; Celum C;
    J Int AIDS Soc; 2021 Jun; 24 Suppl 2(Suppl 2):e25731. PubMed ID: 34164929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trajectories of Oral PrEP Adherence Among Young Kenyan Women: Implications for Promoting Effective PrEP Use.
    Musinguzi N; Pyra M; Bukusi EA; Mugo NR; Baeten JM; Haberer JE;
    AIDS Behav; 2023 Jan; 27(1):171-181. PubMed ID: 35841463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of costing in the introduction and scale-up of HIV pre-exposure prophylaxis: evidence from integrating PrEP into routine maternal and child health and family planning clinics in western Kenya.
    Roberts DA; Barnabas RV; Abuna F; Lagat H; Kinuthia J; Pintye J; Bochner AF; Forsythe S; Gomez GB; Baeten JM; John-Stewart G; Levin C
    J Int AIDS Soc; 2019 Jul; 22 Suppl 4(Suppl Suppl 4):e25296. PubMed ID: 31328443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prepped for PrEP? Acceptability, continuation and adherence among men who have sex with men and transgender women enrolled as part of Vietnam's first pre-exposure prophylaxis program.
    Green KE; Nguyen LH; Phan HTT; Vu BN; Tran MH; Ngo HV; Tieu VTT; Van H; Le TM; Do KQ; Nguyen PA; Ngo TM; Doan AH; Bui DTN; Nguyen TNN; Hang LTX; Tran TT; Luong BQ
    Sex Health; 2021 Mar; 18(1):104-115. PubMed ID: 33653505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Counseling Framework for HIV-Serodiscordant Couples on the Integrated Use of Antiretroviral Therapy and Pre-exposure Prophylaxis for HIV Prevention.
    Morton JF; Celum C; Njoroge J; Nakyanzi A; Wakhungu I; Tindimwebwa E; Ongachi S; Sedah E; Okwero E; Ngure K; Odoyo J; Bulya N; Haberer JE; Baeten JM; Heffron R;
    J Acquir Immune Defic Syndr; 2017 Jan; 74 Suppl 1(Suppl 1):S15-S22. PubMed ID: 27930607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV incidence after pre-exposure prophylaxis initiation among women and men at elevated HIV risk: A population-based study in rural Kenya and Uganda.
    Koss CA; Havlir DV; Ayieko J; Kwarisiima D; Kabami J; Chamie G; Atukunda M; Mwinike Y; Mwangwa F; Owaraganise A; Peng J; Olilo W; Snyman K; Awuonda B; Clark TD; Black D; Nugent J; Brown LB; Marquez C; Okochi H; Zhang K; Camlin CS; Jain V; Gandhi M; Cohen CR; Bukusi EA; Charlebois ED; Petersen ML; Kamya MR; Balzer LB
    PLoS Med; 2021 Feb; 18(2):e1003492. PubMed ID: 33561143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nurse-facilitated preexposure prophylaxis delivery for adolescent girls and young women seeking contraception at retail pharmacies in Kisumu, Kenya.
    Pintye J; Odoyo J; Nyerere B; Achieng P; Araka E; Omondi C; Ortblad KF; Mugambi ML; Baeten JM; Bukusi EA
    AIDS; 2023 Mar; 37(4):617-623. PubMed ID: 36653342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Individual and community-level benefits of PrEP in western Kenya and South Africa: Implications for population prioritization of PrEP provision.
    Mudimu E; Peebles K; Mukandavire Z; Nightingale E; Sharma M; Medley GF; Klein DJ; Kripke K; Bershteyn A
    PLoS One; 2020; 15(12):e0244761. PubMed ID: 33382803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early pre-exposure prophylaxis (PrEP) initiation and continuation among pregnant and postpartum women in antenatal care in Cape Town, South Africa.
    Joseph Davey DL; Mvududu R; Mashele N; Lesosky M; Khadka N; Bekker LG; Gorbach P; Coates TJ; Myer L
    J Int AIDS Soc; 2022 Feb; 25(2):e25866. PubMed ID: 35138678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.